Bridgeway Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19,944
| Closed | -$134K | – | 1419 |
|
|
2023
Q2 | $134K | Hold |
19,944
| – | – | ﹤0.01% | 1212 |
|
|
2023
Q1 | $130K | Sell |
19,944
-69,500
| -78% | -$452K | ﹤0.01% | 1186 |
|
|
2022
Q4 | $763K | Sell |
89,444
-6,700
| -7% | -$57.2K | 0.02% | 794 |
|
|
2022
Q3 | $508K | Buy |
96,144
+30,344
| +46% | +$160K | 0.01% | 890 |
|
|
2022
Q2 | $279K | Sell |
65,800
-36,900
| -36% | -$156K | 0.01% | 1012 |
|
|
2022
Q1 | $360K | Buy |
+102,700
| New | +$360K | 0.01% | 1024 |
|